Skip to main content

Connor, Clark & Lunn Investment Management Ltd.

Position in ABBV — AbbVie Inc.

CIK 1596800 VANCOUVER, A1

Position in ABBV

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$189,103,685
+$113,364,750 QoQ
Shares Held
751,485
+115.8% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.36%
of 13F equity value
Holder Rank
#166
of 4,153 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority Sole 98% Shared 0% None 2%

Common Shares in ABBV Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - General

Healthcare · as of Jun 30, 2026

Connor, Clark & Lunn Investment Management Ltd. holds $830,990,729 across 11 Drug Manufacturers - General names. ABBV ranks #2 (22.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 ABBV
AbbVie Inc.
This page
751,485 $189,103,685

All Filings in ABBV

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $189,103,685 751,485
2026-03-31 $75,738,935 348,241
2025-12-31 $21,335,025 93,374
2025-09-30 $27,975,125 120,822
2025-06-30 $21,655,728 116,667
2025-03-31 $18,076,757 86,277
2024-12-31 $2,344,929 13,196
2024-09-30 $3,900,427 19,751
2024-06-30 $2,900,917 16,913
2024-03-31 $6,148,970 33,767
2023-12-31 $1,066,348 6,881
2023-09-30 $2,794,129 18,745
2023-06-30 $21,260,528 157,801
2023-03-31 $2,314,052 14,520
2022-12-31 $9,411,681 58,237
2022-09-30 $4,060,389 30,254
2022-06-30 $8,060,810 52,630
2022-03-31 $40,103,744 247,386
2021-12-31 $15,909,770 117,502
2021-09-30 $565,346 5,241
2021-06-30 $8,746,383 77,649
2021-03-31 $29,712,342 274,555
2020-12-31 $30,224,121 282,073
2020-09-30 $23,086,446 263,574
2020-06-30 $2,117,055 21,563